Cutler Group’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,200
Closed -$1K 2349
2023
Q4
$1K Buy
+1,200
New +$3.44K ﹤0.01% 3270
2023
Q3
Sell
-1,200
Closed -$2K 3794
2023
Q2
$2K Hold
1,200
﹤0.01% 2965
2023
Q1
$1K Sell
1,200
-4,200
-78% -$17.1K ﹤0.01% 3343
2022
Q4
$1K Buy
+5,400
New +$23.1K ﹤0.01% 3921
2022
Q2
Sell
-21,800
Closed -$9K 4975
2022
Q1
$9K Sell
21,800
-47,500
-69% -$334K ﹤0.01% 3671
2021
Q4
$14K Sell
69,300
-33,900
-33% -$322K ﹤0.01% 3398
2021
Q3
$55K Buy
103,200
+38,700
+60% +$338K ﹤0.01% 2430
2021
Q2
$25K Buy
64,500
+6,800
+12% +$67.1K ﹤0.01% 3100
2021
Q1
$11K Buy
+57,700
New +$803K ﹤0.01% 3707

Other funds holding SRTA

Cutler Group's SRTA Position: Q1 2023 in Review

Cutler Group sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 470 shares — an estimated $1.92K sold.

Cutler Group first reported a position in SRTA in Q1 2021 and held it in 7 quarters. The position peaked at $77K in Q1 2021. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Cutler Group reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 470 Strata Critical Medical Inc shares in Q1 2023, an estimated $1.92K.
  • Cutler Group first reported a position in Strata Critical Medical Inc in Q1 2021 and held it in 7 quarters.
  • Cutler Group's Strata Critical Medical Inc position peaked at $77K in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.